ofloxacin

Clinical Therapeutics
Limited Effect of Later-Generation Fluoroquinolones in the Treatment of Ofloxacin-Resistant and Moxifloxacin-Susceptible Multidrug-Resistant Tuberculosis
Hyun Lee, Soohyun Ahn, Na Young Hwang, Kyeongman Jeon, O Jung Kwon, Hee Jae Huh, Nam Yong Lee, Chang-Ki Kim, Won-Jung Koh
Clinical Therapeutics
In Vivo Pharmacokinetic and Pharmacodynamic Profiles of Antofloxacin against Klebsiella pneumoniae in a Neutropenic Murine Lung Infection Model
Yu-Feng Zhou, Meng-Ting Tao, Wei Huo, Xiao-Ping Liao, Jian Sun, Ya-Hong Liu
Experimental Therapeutics
Impact of recA on Levofloxacin Exposure-Related Resistance Development
Renu Singh, Kimberly R. Ledesma, Kai-Tai Chang, Vincent H. Tam
Clinical Therapeutics
Efficacy and Safety of Nemonoxacin versus Levofloxacin for Community-Acquired Pneumonia
Dirkie J. J. van Rensburg, Reury-Perng Perng, Ismail H. Mitha, Andrè J. Bester, Joseph Kasumba, Ren-Guang Wu, Ming-Lin Ho, Li-Wen Chang, David T. Chung, Yu-Ting Chang, Chi-Hsin R. King, Ming-Chu Hsu
Pharmacology
Bioavailability and Efficacy of Levofloxacin against Francisella tularensis in the Common Marmoset (Callithrix jacchus)
Michelle Nelson, Mark S. Lever, Rachel E. Dean, Peter C. Pearce, Daniel J. Stevens, Andrew J. H. Simpson
Experimental Therapeutics
The Combination of Meropenem and Levofloxacin Is Synergistic with Respect to both Pseudomonas aeruginosa Kill Rate and Resistance Suppression
Arnold Louie, Caroline Grasso, Nadzeya Bahniuk, Brian Van Scoy, David L. Brown, Robert Kulawy, G. L. Drusano
Mechanisms of Action: Physiological Effects
Comparative Study of the Mutant Prevention Concentrations of Moxifloxacin, Levofloxacin, and Gemifloxacin against Pneumococci
Kim Credito, Klaudia Kosowska-Shick, Pamela McGhee, Glenn A. Pankuch, Peter C. Appelbaum
Pharmacology
Pharmacometrics-Based Dose Selection of Levofloxacin as a Treatment for Postexposure Inhalational Anthrax in Children
Fang Li, Partha Nandy, Shuchean Chien, Gary J. Noel, Christoffer W. Tornoe
Experimental Therapeutics
In Vitro Pharmacodynamics of Levofloxacin and Other Aerosolized Antibiotics under Multiple Conditions Relevant to Chronic Pulmonary Infection in Cystic Fibrosis
Paula King, Olga Lomovskaya, David C. Griffith, Jane L. Burns, Michael N. Dudley
Experimental Therapeutics
Efficacy of Aerosol MP-376, a Levofloxacin Inhalation Solution, in Models of Mouse Lung Infection Due to Pseudomonas aeruginosa
Mojgan Sabet, Courtney E. Miller, Thomas G. Nolan, Kathy Senekeo-Effenberger, Michael N. Dudley, David C. Griffith

Main menu

User menu

Search

ofloxacin

Pages